Stay updated with breaking news from Sam Agresta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Whether we partied and danced at Limbo, Jules or any of a myriad of clubs and pubs then or now, Adelaide has had a varied after-dark experience. With CityMag staffers spanning generations, it became clear our nightlife experiences have changed over time.
Infinity Pharmaceuticals, Inc. , a clinical-stage biotechnology company developing eganelisib, a potential first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced...
Share: CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (NASDAQ:FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that Sam Agresta, M.D., M.P.H, Chief Medical officer is scheduled to participate in a Leukemias panel discussion at the Cowen 41 st Annual Healthcare Conference at 11:40 a.m. ET on March 3, 2021. About Foghorn Therapeutics Foghorn ® Therapeutics is discovering and developing a novel class of medicines targeting ge...